286-靶向巨噬细胞的免疫细胞因子用于癌症免疫治疗 episode artwork

EPISODE · Dec 2, 2025 · 18 MIN

286-靶向巨噬细胞的免疫细胞因子用于癌症免疫治疗

from 聊聊Sci

这篇文章重点介绍了一种新型的巨噬细胞靶向免疫细胞因子(immunocytokine),命名为 MiTEs。该研究旨在克服传统免疫细胞因子(ICKs)的全身毒性和治疗局限性,通过将抗TREM2抗体与经过工程改造的IL-2变体融合,并加入一个可被肿瘤微环境(TME)特异性蛋白酶 MMP14 剪切的阻断域,从而实现肿瘤特异性激活。实验数据,包括单细胞RNA测序(scRNA-seq)和体内模型结果,展示了 MiTEs 能够重塑肿瘤免疫微环境,有效激活和协同作用于骨髓细胞、T细胞和NK细胞,增强抗肿瘤免疫反应并显著降低全身副作用。研究人员认为 MiTEs 平台为开发下一代高效、安全的细胞因子疗法提供了新的方向。References: von Locquenghien M, Zwicky P, Xie K, et al. Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy[J]. Cell, 2025.前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Dec 2, 2025

Embed this episode

Ready to play

286-靶向巨噬细胞的免疫细胞因子用于癌症免疫治疗

0:00 18:12

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 聊聊Sci?

This episode is 18 minutes long.

When was this 聊聊Sci episode published?

This episode was published on December 2, 2025.

Can I download this 聊聊Sci episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!